JP2019513722A5 - - Google Patents

Download PDF

Info

Publication number
JP2019513722A5
JP2019513722A5 JP2018551960A JP2018551960A JP2019513722A5 JP 2019513722 A5 JP2019513722 A5 JP 2019513722A5 JP 2018551960 A JP2018551960 A JP 2018551960A JP 2018551960 A JP2018551960 A JP 2018551960A JP 2019513722 A5 JP2019513722 A5 JP 2019513722A5
Authority
JP
Japan
Prior art keywords
pertactin
subject
composition
medicament
bordetella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018551960A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019513722A (ja
JP6993984B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/057468 external-priority patent/WO2017167834A1/en
Publication of JP2019513722A publication Critical patent/JP2019513722A/ja
Publication of JP2019513722A5 publication Critical patent/JP2019513722A5/ja
Application granted granted Critical
Publication of JP6993984B2 publication Critical patent/JP6993984B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018551960A 2016-03-29 2017-03-29 変異ボルデテラ菌株および使用方法 Active JP6993984B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662314843P 2016-03-29 2016-03-29
US62/314,843 2016-03-29
PCT/EP2017/057468 WO2017167834A1 (en) 2016-03-29 2017-03-29 Mutant bordetella strains and methods for use

Publications (3)

Publication Number Publication Date
JP2019513722A JP2019513722A (ja) 2019-05-30
JP2019513722A5 true JP2019513722A5 (enExample) 2020-04-02
JP6993984B2 JP6993984B2 (ja) 2022-02-03

Family

ID=58488973

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018551960A Active JP6993984B2 (ja) 2016-03-29 2017-03-29 変異ボルデテラ菌株および使用方法

Country Status (11)

Country Link
US (4) US10682377B2 (enExample)
EP (2) EP4541809A3 (enExample)
JP (1) JP6993984B2 (enExample)
CN (2) CN114767718A (enExample)
AU (2) AU2017242541B2 (enExample)
CA (1) CA3018126A1 (enExample)
DK (1) DK3436034T3 (enExample)
ES (1) ES3027194T3 (enExample)
FI (1) FI3436034T3 (enExample)
SG (1) SG11201807783UA (enExample)
WO (1) WO2017167834A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0707102B1 (pt) * 2006-03-10 2022-05-31 Institut Pasteur De Lille Composição imunogênica
CA2759280C (en) 2009-04-28 2016-09-20 Inserm (Institut National De La Sante Et De La Recherche Medicale) Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
AU2017242541B2 (en) * 2016-03-29 2022-06-30 Institut National De La Sante Et De La Recherche Medicale (Inserm) Mutant bordetella strains and methods for use
CA3077428A1 (en) 2017-10-18 2019-04-25 Institut Pasteur De Lille Bordetella strains expressing serotype 3 fimbriae
BR112023002549A2 (pt) 2020-08-14 2023-03-07 Iliad Biotechnologies Llc Método de fabricação de uma vacina liofilizada compreendendo bactérias bordetella vivas atenuadas e produto de vacina liofilizada
CN116635517A (zh) 2020-11-17 2023-08-22 伊利亚德生物技术有限公司 与神经退行性疾病相关的神经病理的治疗和预防
JP2025525623A (ja) 2022-07-22 2025-08-05 アンスティチュ ナシヨナル デュ ラ サンテ エト デュ ラ レシェルシェ メディカレ 慢性閉塞性肺疾患の治療のためのボルデテラ(bordetella)菌株の使用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713072B1 (en) 1987-11-02 2004-03-30 Chiron S.R.L. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
GB9115332D0 (en) * 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
FR2718750B1 (fr) 1994-04-19 1996-06-14 Pasteur Institut Protéines recombinantes de l'hémagglutinine filamenteuse de Bordetella, notamment, B. Pertussis, production et application à la production de protéines étrangères ou de principes actifs vaccinants.
CN1147259A (zh) * 1994-04-28 1997-04-09 武田药品工业株式会社 分离百日咳杆菌保护性组分的方法
FR2754543B1 (fr) * 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
FR2840319B1 (fr) 2002-05-30 2004-08-20 Pasteur Institut Souches de bordetella rendues deficientes par attenuation genetique
EP1617805A4 (en) 2003-04-11 2012-07-04 Medimmune Llc METHODS FOR PREVENTING OR TREATING RESPIRATORY CONDITIONS
BRPI0707102B1 (pt) 2006-03-10 2022-05-31 Institut Pasteur De Lille Composição imunogênica
WO2008058396A1 (en) 2006-11-15 2008-05-22 Folia Biotech Inc. Papaya mosaic virus-based vaccines for influenza
EP2134359A4 (en) 2007-02-23 2010-06-16 Penn State Res Found USE OF A NONVIRULENT BORDETELLA MUTANT AS LIVING VACCINE VECTOR
US20100104533A1 (en) 2007-06-18 2010-04-29 Carter William A Early intervention of viral infection with immune activators
CA2759280C (en) * 2009-04-28 2016-09-20 Inserm (Institut National De La Sante Et De La Recherche Medicale) Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
JP5551774B2 (ja) 2009-06-15 2014-07-16 ナショナル ユニヴァーシティー オブ シンガポール インフルエンザワクチン、組成物、および使用方法
US9415077B2 (en) * 2011-11-02 2016-08-16 Institut National De La Sante Et De La Recherche Medicale Effect of an attenuated Bordetella strain against allergic disease
CN102793915B (zh) * 2012-07-25 2013-10-23 天津康希诺生物技术有限公司 一种无细胞百日咳疫苗的生产方法
EP2722338A1 (en) 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel recombinant Bordetella strains
AU2017242541B2 (en) * 2016-03-29 2022-06-30 Institut National De La Sante Et De La Recherche Medicale (Inserm) Mutant bordetella strains and methods for use

Similar Documents

Publication Publication Date Title
JP2019513722A5 (enExample)
US20230381224A1 (en) Mutant Bordetella Strains and Methods of Use
Barbic et al. Role of gamma interferon in natural clearance of Bordetella pertussis infection
US12403188B2 (en) Bordetella strains expressing serotype 3 fimbriae
JP2025160294A (ja) 結核の感染リスクがある人に対する予防剤として、又は感染した結核患者を治療するための二次薬として使用する組成物
KR102040665B1 (ko) 약독화된 폐렴구균 균주를 포함하는 약제학적 조성물 및 이의 용도
CN106794201A (zh) 包含新型温度敏感性分枝杆菌菌株的对分枝杆菌感染症的疫苗组合物
Preston et al. Mouse or man? Which are pertussis vaccines to protect?
CN116574659A (zh) 一株可缓解类风湿性关节炎的长双歧杆菌婴儿亚种及其应用
Ismael et al. Development of a Second-Generation Vaccine against Mycoplasmosis: Preparation of a Fraction Candidate from Mycoplasma bovis and Its Evaluation as a Vaccine Department of Animal Medicine, Faculty of Veterinary Medicine, Department of Medical Microbiolog
HK1262896A1 (en) Mutant bordetella strains and methods for use
HK1262896B (zh) 突变型博德特氏菌属菌株及其使用方法
RU2778094C2 (ru) Композиции для применения в качестве профилактического средства для пациентов с риском туберкулезной инфекции или в качестве вторичных средств для лечения пациентов с туберкулезной инфекцией
Munir et al. Generation of Protective Antibodies in Mice via Inactivated Whole-Cell Vaccine Targeting Multidrug-Resistant Escherichia coli
CN116355827A (zh) 一种治疗结核病的重组卡介苗药物及其应用
CN119931911A (zh) 一种重组rMS::MPT64及其应用
Chakraborty et al. Throat Isolates of β-haemolytic Streptococci, from Rural Bengal Showing Reduced Susceptibility to Many Antibiotics